NCT03657264 - Cardiac Safety Evaluation of P03277 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

June 7, 2018

Study Completion Date

June 7, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

P03277 0.1 mmol/kg

Single intravenous bolus injection at 2 mL/sec

DRUG

Moxifloxacin 400mg

One tablet per os

DRUG

NaCl 0.9%

Single intravenous bolus injection at 2 mL/sec

DRUG

P03277 0.3 mmol/kg

Single intravenous bolus injection at 2 mL/sec

Trial Locations (1)

Clinical Pharmacology unit, SGS-Life Science Service, Antwerp